Cogstate Bids Farewell to Esteemed Non-Executive Director After Long Stint

Confident Investing Starts Here:

• Quickly decipher a business's performance with ' new KPI Data for smart investment decisions
• Get underpriced, financially robust stocks delivered directly to your inbox. using the 'Smart Value Newsletter'

Cogstate Ltd ( (AU:CGS) ) has issued an announcement.

Cogstate Ltd. has declared that Mr. Richard van den Broek, a non-executive director, will be retiring. He joined the firm in 2010 and became its inaugural U.S.-based non-executive director. With a background as a healthcare analyst and extensive experience investing in the pharmaceuticals/biotechnology sector, Mr. Van Den Broek brought valuable insights into drug development processes and industry shifts during his tenure. As Cogstate undergoes significant technological progressions in measuring cognition, this change occurs. Despite stepping down from his role, he will retain his position as a stakeholder and consultant for the organization.

The latest analyst assessment regarding this is (AU:CGS) stock is a Buy with a A$1.80 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page .

More about Cogstate Ltd

Cogstate Ltd is a neuroscience tech firm dedicated to enhancing brain health evaluations to expedite the creation of novel medications and facilitate early clinical observations within healthcare settings. They deliver quick, dependable, and extremely sensitive digital cognitive exams along with support for eClinical Outcome Assessment solutions. By partnering with biopharma firms, research organizations, and medical service providers, Cogstate offers precise digital indicators of mental function; notable collaborations include an agreement with drugmaker Eisai for distributing their products in both the U.S. and Asia markets.

Average Trading Volume: 126,100

Technical Sentiment Signal: Buy

Current Market Cap: A$228.7M

Find additional information about CGS stock here. ’ Stock Analysis page .

Disclaimer & Disclosure Report an Issue

Trending Articles

• 'Time to Exit the Bear Camp,' Urges Leading Investor Regarding Nvidia Stock
• "May Breach Federal Anti-Kickback Regulations": Paramount Shares (NASDAQ:PARA) Climb Further Amid Additional Senate Wins
• Ford Surpasses Nürburgring Once More: Ford Stock (NYSE:F) Drops Following Fresh Insights

Bagikan Artikel ini